Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages.

BACKGROUND The cause of corticosteroid-resistant (CR) asthma is unknown. OBJECTIVE We sought to perform gene microarray analyses by using bronchoalveolar lavage (BAL) cells from well-characterized subjects with CR asthma and subject with corticosteroid-sensitive (CS) asthma to elucidate the differential expression of genes that contribute to the development of corticosteroid resistance. METHODS The patients were characterized as having CR or CS asthma based on FEV(1) percent predicted improvement after a 1-week course of oral prednisone. Expression of selected gene targets was verified by means of real-time PCR and ELISA. RESULTS Microarray analyses demonstrated significantly higher levels (>3-fold increase, P < .05) of transcripts for TNF-alpha, IL-1 alpha, IL-1 beta, IL-6, CXCL1, CXCL2, CXCL3, CXCL8 (IL-8), CCL3, CCL4, and CCL20 in BAL cells of subjects with CR asthma. These findings, confirmed by means of RT-PCR in additional BAL samples, were consistent with classical macrophage activation by bacterial products. In contrast, markers of alternatively activated macrophages, arginase I and CCL24, were decreased. Genes associated with activation of the LPS signaling pathway (early growth response 1, dual-specificity phosphatase 2, molecule possessing ankyrin repeats induced by LPS, and TNF-alpha-induced protein 3) were significantly increased in BAL samples from subjects with CR asthma (P < .05). These patients had significantly higher amounts (1444.0 +/- 457.3 pg/mg total protein) of LPS in BAL fluid than seen in subjects with CS asthma (270.5 +/- 216.0 pg, P < .05), as detected by using the LAL assay and confirmed by means of gas chromatographic/mass spectrometric analysis. Prolonged exposure to LPS induced functional steroid resistance to dexamethasone in normal human monocytes, as demonstrated by persistently increased IL-6 levels in the presence of dexamethasone. CONCLUSIONS Classical macrophage activation and induction of LPS signaling pathways along with high endotoxin levels detected in BAL fluid from subjects with CR asthma suggest that LPS exposure might contribute to CR asthma.

[1]  R. Scott,et al.  Clarithromycin targets neutrophilic airway inflammation in refractory asthma. , 2008, American journal of respiratory and critical care medicine.

[2]  W. Busse,et al.  Steroid-resistant asthma. , 1993, The Journal of allergy and clinical immunology.

[3]  R. Martin,et al.  Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  N. Mackman,et al.  Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. , 1997, The Journal of biological chemistry.

[5]  Richard J Martin,et al.  Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. , 2006, American journal of respiratory and critical care medicine.

[6]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[7]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[8]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[9]  P. Moynagh,et al.  Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein. , 2003, Biochemical and biophysical research communications.

[10]  M. Gotfried.  Macrolides for the treatment of chronic sinusitis, asthma, and COPD. , 2004, Chest.

[11]  N. Mackman,et al.  Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. , 2001, Blood.

[12]  S. Szefler,et al.  Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. , 1994, The Journal of clinical investigation.

[13]  A. Liu.  Endotoxin exposure in allergy and asthma: reconciling a paradox. , 2002, The Journal of allergy and clinical immunology.

[14]  D. Milton,et al.  Recombinant factor C assay for measuring endotoxin in house dust: comparison with LAL, and (1 --> 3)-beta-D-glucans. , 2006, American journal of industrial medicine.

[15]  T. Platts-Mills,et al.  Airborne endotoxin in homes with domestic animals: implications for cat-specific tolerance. , 2005, The Journal of allergy and clinical immunology.

[16]  Stephen C Lazarus,et al.  Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .

[17]  M. Morimatsu,et al.  MAIL, a novel nuclear IκB protein that potentiates LPS‐induced IL‐6 production , 2000 .

[18]  I. Pavord,et al.  Evidence of a role of tumor necrosis factor alpha in refractory asthma. , 2006, The New England journal of medicine.

[19]  P. Barnes.  Update on asthma. , 2003, The Israel Medical Association journal : IMAJ.

[20]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[21]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[22]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[23]  M. Morimatsu,et al.  Transcriptional regulation of the MAIL gene in LPS-stimulated RAW264 mouse macrophages. , 2004, Gene.

[24]  B. Thiers.  Tumour Necrosis Factor (TNFα) as a Novel Therapeutic Target in Symptomatic Corticosteroid Dependent Asthma , 2006 .

[25]  J. Travers,et al.  Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. , 2003, The Journal of allergy and clinical immunology.

[26]  Bo Zhu,et al.  LPS induces pulmonary intravascular macrophages producing inflammatory mediators via activating NF‐κB , 2003, Journal of cellular biochemistry.

[27]  N. Mackman,et al.  Lipopolysaccharide Induction of the Tumor Necrosis Factor-α Promoter in Human Monocytic Cells , 1997, The Journal of Biological Chemistry.

[28]  J. Kiley,et al.  Asthma phenotypes , 2007, Current opinion in pulmonary medicine.

[29]  E. Silverman,et al.  Heterogeneity of therapeutic responses in asthma. , 2000, British medical bulletin.

[30]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[31]  M. Klinnert,et al.  Metropolitan home living conditions associated with indoor endotoxin levels. , 2001, The Journal of allergy and clinical immunology.

[32]  W. Moore,et al.  Update in asthma 2006. , 2007, American journal of respiratory and critical care medicine.

[33]  R. Lockey,et al.  Endotoxin exposure and symptoms in asthmatic children , 1997, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[34]  M. Morimatsu,et al.  MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production. , 2000, FEBS letters.

[35]  Qutayba Hamid,et al.  Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. , 2003, The Journal of clinical investigation.

[36]  P. Howarth,et al.  Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. , 2005, Thorax.

[37]  P. Selecky,et al.  Position Paper on Guidelines for Fiberoptic Bronchoscopy in Adults , 1987 .

[38]  D. Hume,et al.  Endotoxin signal transduction in macrophages , 1996, Journal of leukocyte biology.

[39]  P. Henson,et al.  Lipopolysaccharide stimulates monocyte adherence by effects on both the monocyte and the endothelial cell. , 1989, Journal of immunology.

[40]  Yee Hwa Yang,et al.  Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids , 2007, Proceedings of the National Academy of Sciences.

[41]  R. Sergysels,et al.  Domestic endotoxin exposure and clinical severity of asthma , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  G. Chrousos,et al.  Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β , 1997, The Journal of experimental medicine.

[43]  A. Mantovani,et al.  Analysis of the Gene Expression Profile Activated by the CC Chemokine Ligand 5/RANTES and by Lipopolysaccharide in Human Monocytes1 , 2002, The Journal of Immunology.

[44]  J. Bloom,et al.  Update on glucocorticoid action and resistance. , 2003, The Journal of allergy and clinical immunology.

[45]  J. Douwes,et al.  Interlaboratory evaluation of endotoxin analyses in agricultural dusts--comparison of LAL assay and mass spectrometry. , 2005, Journal of environmental monitoring : JEM.

[46]  J. Gulcher,et al.  Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Williams,et al.  Endotoxin Exposure Is a Risk Factor for Asthma: The National Survey of Endotoxin in United States Housing , 2007, Pediatrics.

[48]  B. Smart.  Childhood Asthma After Bacterial Colonization of the Airway in Neonates , 2008, Pediatrics.

[49]  E. R. Sutherland,et al.  Asthma and atypical bacterial infection. , 2007, Chest.

[50]  J. Lafitte,et al.  Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. , 1999, American journal of respiratory and critical care medicine.

[51]  P. Barnes,et al.  The costs of asthma. , 1996, The European respiratory journal.

[52]  R. Pauwels,et al.  Severity of asthma is related to endotoxin in house dust. , 1996, American journal of respiratory and critical care medicine.

[53]  William M Vollmer,et al.  Association of asthma control with health care utilization: a prospective evaluation. , 2002, American journal of respiratory and critical care medicine.